+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
3SBio Inc - logo

3sbio is a biotechnology company that creates biopharmaceutical products. The company was incorporated in 2006, and is headquartered in Shenyang, China. It is a subsidiary of Decade Sunshine Limited. Their products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; and EPIAO, an injectable recombinant human erythropoietin for anemia associated with chronic kidney disease (CKD) and chemotherapy, as well as to reduce allogeneic blood transfusion in surgery patients. 3sbio sell their products to a range of countries including: Brazil, Colombia, Costa Rica ,Dominican Republic, Egypt, El Salvador, Guatemala, Laos, Mongolia, Myanmar, Pakistan, Paraguay, Philippines, Sri Lanka, Thailand and Trinidad and Tobago.

Non-Hodgkin Lymphoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3999 Pages
  • Global
From
Aplastic Anaemia Pipeline Analysis 2019 (H1) - Product Thumbnail Image

Aplastic Anaemia Pipeline Analysis 2019 (H1)

  • Report
  • May 2019
  • 79 Pages
  • Global
From
Diabetic Macular Edema - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 319 Pages
  • Global
From
Retinal Vein Occlusion - Pipeline Review, H1 2020 - Product Thumbnail Image

Retinal Vein Occlusion - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 93 Pages
  • Global
From
Age Related Macular Degeneration - Pipeline Review, H1 2020 - Product Thumbnail Image

Age Related Macular Degeneration - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 864 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2020 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 576 Pages
  • Global
From
Idiopathic Thrombocytopenic Purpura - Pipeline Review, H2 2020 - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 180 Pages
  • Global
From
Choroidal Neovascularization - Pipeline Review, H2 2019 - Product Thumbnail Image

Choroidal Neovascularization - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 57 Pages
  • Global
From
Hypercholesterolemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Hypercholesterolemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 269 Pages
  • Global
From
Thrombocytopenia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Thrombocytopenia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 602 Pages
  • Global
From
Amenorrhea - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Amenorrhea - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 140 Pages
  • Global
From
Interleukin 1 - Pipeline Review, H2 2020 - Product Thumbnail Image

Interleukin 1 - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 156 Pages
  • Global
From
From
From
From
From
From
3SBio Inc (1530) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

3SBio Inc (1530) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • September 2023
  • 47 Pages
From
Loading Indicator